Stock Evaluator: Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Shuttle Pharmaceuticals Holdings, Inc. SHPH

$4.08 0.04 0.99%
October 1, 2026 1:22:52 PM EST November 10, 2021 Volume: 11,134
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Biotechnology

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Commentary & Analysis


Financial Summary

Share Statistics SHPH Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $19.2 $257.1 10%
Shares Out (Mil) 1.0 54.0 5%
Institutional Ownership 83.0% 93.2% 51%
Float (Mil) 4.8 41.3 12%
Beta 1.22 0.95 72%
Avg Daily Volume (000s) 37 728 25%
Price Change
(52-week)
(89.4%) 50.6% 5%
Growth SHPH Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 12.8% na
Net Income (5yr) (71.0%) (10.1%) 4%
EPS (5yr) na 15.7% na
Dividends (5yr) na 0.0% na
Cash Flow (5yr) na (15.7%) na
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials SHPH Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) na $37 na
Net Income (TTM) (Mil) ($10) ($44) 29%
EPS (TTM) ($20.286) ($1.600) 3%
Operating Cash Flow (TTM) (Mil) ($7) ($33) 23%
Net Cash Flow (TTM) (Mil) na $2 na
Long-Term Debt (Q1) (Mil) $0 $4 10%
Enterprise Value (Q1) (Mil) $19 $173 11%
Valuation SHPH Industry
Median
Percentile
(All Stocks)
P/B 0.21 2.52 3%
P/E na 19.4 na
Dividend Yield na 0.0% na
PEG (5yr hist) na 1.0 na
Ratios SHPH Industry
Median
Percentile
(All Stocks)
Gross Margin na 68.2% na
Net Margin na (73.7%) na
ROA (72.5%) (47.7%) 8%
ROE (90.1%) (54.9%) 10%
Liabilities to Assets 15.9% 29.0% 10%
F-Score 3 3 na

Shuttle Pharmaceuticals Holdings, Inc. did not pass any screens on 9/30/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors